Nasus Pharma Ltd Increase (Decrease) in Accrued Liabilities
Nasus Pharma Ltd (NSRX) reported Increase (Decrease) in Accrued Liabilities of -$182.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-03-25
| Period end | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|
| 2025-12-31 | -$182.00K 20-F · filed 2026-03-25 | |
| 2025-06-30 | $178.00K 6-K · filed 2025-12-29 | |
| 2024-12-31 | $322.00K 20-F · filed 2026-03-25 | |
| 2024-06-30 | $98.00K 6-K · filed 2025-12-29 | |
| 2023-12-31 | $271.00K 20-F · filed 2026-03-25 |